Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
250 participants
OBSERVATIONAL
2020-08-19
2023-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with mild haemophilia A or B
(FVIII or IX \>5 %, ≥ 18 years' old)
No interventions assigned to this group
Patients with moderate haemophilia A or B
(FVIII or IX 1-5 %, ≥ 18 years' old)
No interventions assigned to this group
Patients with severe haemophilia A or B
(FVIII or IX \<1 %, ≥ 18 years' old)
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Submitted written consent to participate in the study
Exclusion Criteria
* PWH without written consent
* PWH \< 18 years of age
* Secondary osteoporosis
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Bayer
INDUSTRY
PD Dr. Andreas Strauß
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
PD Dr. Andreas Strauß
specialist for orthopaedics and trauma surgery
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Andreas Strauß, PD Dr.
Role: PRINCIPAL_INVESTIGATOR
Medicine of the University of Bonn
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital of Bonn
Bonn, Northrhine Westfalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Andreas Strauß, PD Dr.
Role: primary
References
Explore related publications, articles, or registry entries linked to this study.
Ransmann P, Bruhl M, Hmida J, Goldmann G, Oldenburg J, Schildberg FA, Ossendorff R, Tomschi F, Schmidt A, Hilberg T, Strauss AC. Physical activity and handgrip strength in patients with mild, moderate and severe haemophilia: Impacts on bone quality and lean mass. PLoS One. 2025 Mar 26;20(3):e0319951. doi: 10.1371/journal.pone.0319951. eCollection 2025.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-003072-41
Identifier Type: EUDRACT_NUMBER
Identifier Source: secondary_id
NISOSTEO20200529
Identifier Type: -
Identifier Source: org_study_id